AU2002214546A1 - Bicyclic pyrimidin-4-one based inhibitors of factor xa - Google Patents

Bicyclic pyrimidin-4-one based inhibitors of factor xa

Info

Publication number
AU2002214546A1
AU2002214546A1 AU2002214546A AU1454602A AU2002214546A1 AU 2002214546 A1 AU2002214546 A1 AU 2002214546A1 AU 2002214546 A AU2002214546 A AU 2002214546A AU 1454602 A AU1454602 A AU 1454602A AU 2002214546 A1 AU2002214546 A1 AU 2002214546A1
Authority
AU
Australia
Prior art keywords
factor
based inhibitors
bicyclic pyrimidin
pyrimidin
bicyclic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002214546A
Inventor
Wenrong Huang
Zhaozhong Jon Jia
Wenhao Li
Robert M. Scarborough Jr.
Lingyan Wang
Penglie Zhang
Bing-Yan Zhu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
COR Therapeutics Inc
Original Assignee
COR Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by COR Therapeutics Inc filed Critical COR Therapeutics Inc
Publication of AU2002214546A1 publication Critical patent/AU2002214546A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/86Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88Oxygen atoms
    • C07D239/91Oxygen atoms with aryl or aralkyl radicals attached in position 2 or 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
AU2002214546A 2000-09-29 2001-10-01 Bicyclic pyrimidin-4-one based inhibitors of factor xa Abandoned AU2002214546A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23633100P 2000-09-29 2000-09-29
US60/236,331 2000-09-29
PCT/US2001/030335 WO2002026718A2 (en) 2000-09-29 2001-10-01 Bicyclic pyrimidin-4-one based inhibitors of factor xa

Publications (1)

Publication Number Publication Date
AU2002214546A1 true AU2002214546A1 (en) 2002-04-08

Family

ID=22889064

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002214546A Abandoned AU2002214546A1 (en) 2000-09-29 2001-10-01 Bicyclic pyrimidin-4-one based inhibitors of factor xa

Country Status (2)

Country Link
AU (1) AU2002214546A1 (en)
WO (1) WO2002026718A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002317377A1 (en) * 2001-07-20 2003-03-03 Cancer Research Technology Limited Biphenyl apurinic/apyrimidinic site endonuclease inhibitors to treat cancer
SE0102764D0 (en) 2001-08-17 2001-08-17 Astrazeneca Ab Compounds
AU2003301662A1 (en) * 2002-10-21 2004-05-13 Bristol-Myers Squibb Company Quinazolinones and derivatives thereof as factor xa inhibitors
AR051596A1 (en) * 2004-10-26 2007-01-24 Irm Llc CONDENSED HETEROCICLIC COMPOUNDS NITROGENATED AS INHIBITORS OF THE ACTIVITY OF THE CANABINOID RECEIVER 1; PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND THEIR EMPLOYMENT IN THE PREPARATION OF MEDICINES FOR THE TREATMENT OF FOOD DISORDERS
WO2007000655A2 (en) * 2005-06-28 2007-01-04 Orchid Research Laboratories Limited Novel pyrazolopyrimidinone derivatives
CN101506210A (en) 2006-08-23 2009-08-12 神经能质公司 2-phenoxy pyrimidinone analogues
US8952021B2 (en) * 2009-01-08 2015-02-10 Resverlogix Corp. Compounds for the prevention and treatment of cardiovascular disease
UY35675A (en) 2013-07-24 2015-02-27 Novartis Ag SUBSTITUTED DERIVATIVES OF QUINAZOLIN-4-ONA
PL3164380T3 (en) * 2014-07-03 2022-04-04 Celgene Quanticel Research, Inc. Inhibitors of lysine specific demethylase-1

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ192392A (en) * 1978-12-19 1983-02-15 M Ishikawa 3-(substituted (phenyl or pyridyl)) -3,4-dihydroquinazolin-4-ones
DE19816983A1 (en) * 1998-04-17 1999-10-21 Boehringer Ingelheim Pharma New bicyclic heteroaromatic amidine or nitrile compounds, used as thrombin inhibitors, antithrombotic agents or intermediates

Also Published As

Publication number Publication date
WO2002026718A2 (en) 2002-04-04
WO2002026718A3 (en) 2002-08-29

Similar Documents

Publication Publication Date Title
AU6762400A (en) Inhibitors of factor xa
AU5723500A (en) Inhibitors of factor xa
AU5158100A (en) Inhibitors of factor xa
AU5283900A (en) Inhibitors of factor xa
AU3857300A (en) Inhibitors of factor xa
AU2002351179A1 (en) Glycinamides as factor xa inhibitors
AU2001249399A1 (en) Isoquinolone inhibitors of factor xa
AU2001273040A1 (en) Factor xa inhibitors
IL148698A0 (en) INHIBITORS OF FACTOR Xa
AU2001252574A1 (en) Novel bicyclic compounds
AU5283600A (en) Inhibitors of factor xa
AU2002352221A1 (en) Bicyclic n-arylamides
AU2003254051A1 (en) Pyrazolopyrimidines as kinase inhibitors
AU2003261204A1 (en) Pyrazolopyrimidines as kinase inhibitors
AU2002336311A1 (en) Bicyclic compound
AU2001249397A1 (en) Oxindole inhibitors of factor xa
AU2002303264A1 (en) Fused heterocyclic inhibitors of factor xa
AU2001297648A1 (en) Substituted carboxamides as inhibitors of factor xa
AU2001294824A1 (en) Piperazine based inhibitors of factor xa
AU2003240668A1 (en) Attenuation of metapneumovirus
AU2002214546A1 (en) Bicyclic pyrimidin-4-one based inhibitors of factor xa
AU2002306734A1 (en) Inhibitors of plasmepsins
AU2002338734A1 (en) Use of phosphorodiesterase IV inhibitors
AU2002222933A1 (en) Inhibitors of factor xa
AU2002357177A1 (en) Methods of co2-assisted reactive extrusion